With over 15 years in the life science industry, Peter strives to provide his clients with the tools they need to make impactful business decisions. He has extensive experience in global pricing and market access dynamics paired with commercialization strategy know-how, both critical areas of understanding to succeed in an ever-evolving and competitive landscape. Peter has led engagements across all major therapeutic areas, with particular emphasis on cardiometabolic disease, immunology, and rare disease. In these spaces, Peter strives to deliver actionable recommendations through a highly collaborative approach with biopharma clients at the brand, franchise, and corporate levels.
Peter has a PhD in Biological Chemistry from MIT with additional training from the Sloan School of Management and graduated magna cum laude with an AB in Chemistry from Occidental College.
Debbi Amanti Belanger
Klaus Bredl
Seth Berman
Steven Chao
Rishi Dalsania
David Gilman
Kim Goh
Ketan Kapadia
Philip Kenner
Eva Kersey
Stuart MacGregor
David McClain
Richard Mynahan
Kevin Richard
Mike Rizzo
Mike Roy
Bill Shew
Ryan Tubman
Sam Ulin
Debbie Zhuang
Jim Caruso
Sidnee Pinho
Kristine Hyde
Jonathan Betts
Dean Griffiths
Jonathan Hodgson
Slater Hurst
Andrew Kang
Dave Konciak
Alexander Lehrman
Charles Mathews
Olivia Piccione
Kai-Ming Pu
Sarah Stapleton
Brian Quinn
Michael Agne
Jessica Berard
Beko Binder
Liang Dong
Maneesh Gujrati
Peter Goldman
Austin Hubbert
Owen Im
Jonny Juliano
Patrick Kuettner
Joanna Lee
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Matthew Pfister
Cem Salfati
Kelsey Yardumian
Lainey Miller
Melanie Robinson